Sunedison Memo
Sunedison Memo
Sunedison Memo
Transaction ID 58601559
Case No. 11898-CB
) CONSOLIDATED
) C.A. NO. 11898-CB
REDACTED VERSION-FILED: February 19, 2016
SUNEDISON DEFENDANTS MEMORANDUM IN OPPOSITION TO
PLAINTIFFS MOTION FOR PRELIMINARY INJUNCTION
OF COUNSEL:
Gregory P. Joseph
Pamela Jarvis
Mara Leventhal
Honey Kober
Gregory O. Tuttle
Roman Asudulayev
Joseph Hage Aaronson LLC
485 Lexington Avenue
30th Floor
New York, New York 10017
(212) 407-1210
Dated: February 12, 2016
TABLE OF CONTENTS
Page
TABLE OF AUTHORITIES .................................................................................... ii
PRELIMINARY STATEMENT ............................................................................... 1
FACTS ....................................................................................................................... 4
ARGUMENT ........................................................................................................... 33
THE INJUNCTION PLAINTIFF SEEKS IS EFFECTIVELY PERMANENT ..... 33
I.
II.
III.
B.
2.
B.
C.
The Court Could Enjoin the Take/Pay Agreement in the Future ..56
CONCLUSION ........................................................................................................ 58
i
TABLE OF AUTHORITIES
Page(s)
Cases
7547 Partners v. Beck,
682 A.2d 160 (Del. 1996) .............................................................................. 37
AB Value Partners, LP v. Kreisler Mfg. Corp.,
2014 WL 7150465 (Del. Ch. Dec. 16, 2014) ................................................ 34
AM Gen. Holdings LLC v. Renco Grp.,
2012 WL 6681994 (Del. Ch. Dec. 21, 2012) ................................................ 59
Angelo, Gordon & Co. v. Allied Riser Commcns Corp.,
805 A.2d 221 (Del. Ch. 2002) .........................................................52 n.11, 55
Bayard v. Martin,
101 A.2d 329 (Del. 1953) ......................................................................55 n.12
Braunschweiger v. Am. Home Shield Corp.,
1989 WL 128571 (Del. Ch. Oct. 26, 1989) ................................................... 58
Brown v. Automated Mktg. Sys., Inc,
1982 WL 8782 (Del. Ch. Mar. 22, 1982) ...................................................... 37
Cantor Fitzgerald, L.P. v. Cantor,
724 A.2d 571 (Del. Ch. 1998) ....................................................................... 58
Del. Open MRI Radiology Assocs., P.A. v. Kessler,
898 A.2d 290 (Del. Ch. 2006) ....................................................................... 49
Emerald Partners v. Berlin,
2003 WL 21003437 (Del. Ch. Apr. 28, 2003),
affd, 2003 WL 23019210 (Del. Dec. 23, 2003) .....................................40, 47
Gesoff v. IIC Indus., Inc.,
902 A.2d 1130 (Del. Ch. 2006) ..................................................................... 45
ii
iv
vi
REDACTED
Appaloosa
conspicuously fails to quantify the potential damages it claims SunEdison could
not satisfy in the absence of an injunction. In fact,
REDACTED
$185 million, and that amount shrinks quarterly once the loan secured by the
Take/Pay Agreement issues. This amount is well within SunEdisons capacity to
pay. Litvak Report at 11, 90-91.
Second, Appaloosa seeks an injunction to prevent supposed harm to TERP
from the Take/Pay Agreement, but that harm is both speculative and could occur
only in the future, depending on whether or when TERPs obligation to purchase
arises, the price of the assets to be purchased, the condition of the capital markets
and numerous other variables, including how long the Take/Pay remains in effect.
An injunction would, however, immediately harm Vivint, SunEdison and TERP.
x Vivint and its shareholders would lose the merger.
x SunEdison would be subject to a potentially catastrophic lawsuit from
Vivint.
x The resulting harm to SunEdison
REDACTED
REDACTED
REDACTED
The Vivint acquisition followed the template of the January 2015 First
Wind acquisition, in which SunEdison bought First Winds
development platform and TERP bought its operating assets.
REDACTED
REDACTED
REDACTED
REDACTED
company on July 23, 2014. Ex. 3 at 10. As a YieldCo, TERPs primary business
objective is to increase the cash dividends we pay to our shareholders over time.
Ex. 3 at 8. SunEdison is a controlling shareholder of TERP and has the right to
specifically designate two TERP directors in addition to its voting power to elect
other directors. Id. at 3 at 42; Ex. 4 at 8.
Individual Defendants. Since November 20, 2015, Peter Blackmore, Jack
Jenkins-Stark and Christopher Compton (Individual Defendants) have served
as independent directors on TERPs board and members of its Corporate
Governance and Conflicts Committee (Conflicts Committee or Committee),
which review[s] and approve[s] potential conflict transactions between TERP
and SunEdison. Ex. 9 at 2(b). Blackmore previously served as an independent
director of SunEdison.
Appaloosa. Plaintiff, a hedge fund,
DevCo/YieldCo Structure.
REDACTED
(Karcanias Report 1.15, 2.1-2.9). The industry remains in its infancy with only
15 YieldCos publicly traded worldwide.
REDACTED
years following IPO). SunEdison provides TERP nearly all of its employees,
operations, and administrative support.
Given the DevCo/YieldCo relationship and SunEdisons ownership interest
in TERP,
REDACTED
Certain of TERPs power purchase agreements (PPAs) and projectlevel financing arrangements include provisions that would permit
the counterparty to terminate the contract or accelerate maturity in the
event SunEdison ceases to control TERP and the termination or
acceleration of any of these agreements could have a material
adverse effect on TERP. Ex. 3 at 25.
customers. Ex. 1 at 1.
REDACTED
REDACTED
SunEdison used the July Vivint Transaction to force[ ] low quality assets on
TERP (e.g., 2, 30, 73(f), 106; Pl. Mem. 3, 53) is groundless. TERP REDACTED
REDACTED
TERP was intimately involved in negotiating the structure and terms of the
Vivint transaction and financing.
REDACTED
REDACTED
REDACTED
As Vivint requested,
the transaction was structured as a merger agreement between SunEdison and
Vivint (July Merger Agreement) (Ex. 22), pursuant to which SunEdison would
acquire Vivint for $2.2 billion, payable in cash, stock and convertible notes, to be
funded in part by (a) the concurrent sale of Vivints rooftop solar portfolio of 523
megawatts (MW) to TERP (the initial Drop Down Transaction) for $922
million, pursuant to the July 20, 2015 Purchase Agreement between SunEdison and
Terra LLC (July Purchase Agreement) (Compl. Ex. 1), and (b) a $500 million
REDACTED
(the Goldman Loan or Term Facility, and with the July Merger and Purchase
Agreements, the July Vivint Transaction). Ex. 24.
REDACTED
10
REDACTED
11
REDACTED
12
REDACTED
It was ultimately agreed that the price of Future Drop Downs would be at the
lesser of fair market value (to be determined by an appraisal) or a guaranteed
return to TERP. Ex. 21 at Ex. B at 1578-79.
REDACTED
13
REDACTED
14
REDACTED
15
REDACTED
16
REDACTED
17
REDACTED
Adverse Effect (MAE) within the July Merger Agreement. Section 8.03(l)
specifically excluded from the definition of a Company Material Adverse Effect
any changes in the economy or the financial or securities markets...or the
industry...in which [Vivint] operates and any failure in and of itself of [Vivint] to
meet any internal or published projections.... Ex. 22 8.03(l). This Court has
held that where, as here, a purchaser agrees that a sellers failure to meet
projections does not constitute an MAE, the parties have specifically allocated the
risk to [the purchaser] that [the sellers] performance would not live up to
managements expectations. Hexion Specialty Chems., Inc. v. Huntsman Corp.,
965 A.2d 715, 741 (Del. Ch. 2008). No Delaware court has ever found an MAE in
the context of a merger agreement, nor could one be expected to do so on grounds
expressly disavowed in the MAE definition.
The July Merger Agreement authorized Vivint to seek injunctive relief to
compel specific performance.
Ex. 22 8.11.
Vivints board began preparing for, and threatening, litigation to compel specific
performance of the July Merger Agreement. Ex. 5 at 61, 63, 67. Accordingly,
non-performance by SunEdison threatened an injunctive proceeding by Vivint
19
REDACTED
None of the reasons Plaintiff advances to establish that TERP was not
bound by the original deal, Pl. Mem. 19, withstands analysis.
REDACTED
REDACTED
21
Renegotiation.
REDACTED
22
REDACTED
23
REDACTED
24
REDACTED
25
REDACTED
REDACTED
REDACTED
SunEdisons
REDACTED
REDACTED
28
REDACTED
REDACTED
29
REDACTED
REDACTED
REDACTED
REDACTED
30
REDACTED
REDACTED
31
REDACTED
REDACTED
32
REDACTED
Third, Plaintiff claims that it will be impossible to undo the transaction if the
transaction is not enjoined (Pl. Mem. 58-59), but nothing will prevent the Court
from enjoining the Take/Pay in the future if any dropdown should prove unfair to
TERP.
ARGUMENT
THE INJUNCTION PLAINTIFF SEEKS IS EFFECTIVELY PERMANENT
Plaintiffs motion seeks a preliminary injunction, an extraordinary remedy
that will never be granted unless earned.
Sholder Litig., 2014 WL 7246436, at *12 (Del. Ch. Dec. 19, 2014). In fact, there
is nothing preliminary about the relief Plaintiff seeks. The injunction would have
the effect of finally quashing the Vivint merger because it would prevent the
merger from closing before the March 18, 2016 termination date.
Ex. 22 at
33
(a) actual
success on the merits, (b) irreparable harm,(c) that, on balance, the equities
weigh in favor of issuing the injunction and (d) that the movant is entitled to
judgment as a matter of law, view[ing] the evidence presented in the light most
favorable to the non-moving party. Weichert Co. v. Young, 2007 WL 4372823, at
*2 (Del. Ch. Dec. 7, 2007) (considering injunction application under summary
judgment standard).
34
Plaintiff cannot satisfy these standards or even the lesser standards for a
preliminary injunction. The record refutes Plaintiffs claim that SunEdison used its
control to force TERP into the Challenged Transaction.
I.
REDACTED
Plaintiff pegs its fiduciary breach claim on several core features of the
Challenged Transaction that are supposedly unfair that (a) the Vivint assets are
residential (105-06; Pl. Mem. 52); (b) TERP would provide financing for the
merger through the initial Drop Down (111; Pl. Br. 51); and (c) REDACTED
35
52). But even if any of these objections had merit, and none does,8 Plaintiff lacks
standing to raise them because each of those features was an agreed term before
Plaintiff ever became a stockholder. 8 Del. C. 327; La. Mun. Police Emps. Ret.
Sys. v. Crawford, 918 A.2d 1172, 1184 (Del. Ch. 2007) ([W]ell-settled law
precludes plaintiffs from challenging a board decision that occurred before
plaintiffs stock ownership arose.); accord Ryan v. Gifford, 918 A.2d 341, 358-59
(Del. Ch. 2007).
Section 327 furthers Delawares longstanding public policy against the evil
of purchasing stock in order to attack a transaction which occurred prior to the
purchase of the stock. Polygon Glob. Opportunities Master Fund v. W. Corp.,
2006 WL 2947486, at *5 (Del. Ch. Oct. 12, 2006); see also, e.g., In re AbbVie Inc.
Sholder Deriv. Litig., 2015 WL 4464505, at *4 (Del. Ch. July 21, 2015).
A plaintiff who buys into a disclosed corporate transaction has not been
injured in her expectation and...she has no grounds to complain as to the judgment
of the defendants in determining the...price o[r] as to the purpose which motivated
8
the board.... Brown v. Automated Mktg. Sys., Inc, 1982 WL 8782, at *2 (Del. Ch.
Mar. 22, 1982). A plaintiff challenging a proposed merger...must have been a
stockholder at the time the terms of the merger were agreed upon because it is the
terms of the merger, rather than the technicality of its consummation, which are
challenged. In re Beatrice Cos. Litig., 1987 WL 36708, at *3 (Del. Feb. 20,
1987); accord 7547 Partners v. Beck, 682 A.2d 160, 162-63 (Del. 1996).
Appaloosa did not own any TERP stock until
REDACTED
B.
REDACTED
REDACTED
38
REDACTED
39
REDACTED
transaction is fair.
Delaware law is clear that perfection is not possible or expected. In re
Trados, Inc. Sholder Litig., 73 A.3d 17, 56 (Del. Ch. 2013). If a flaw is detected,
the magnitude of process flaw required to find an unfair process must be one
that would be likely to lead to an unfair result. Emerald Partners v. Berlin, 2003
WL 21003437, at *28 (Del. Ch. Apr. 28, 2003), affd, 2003 WL 23019219 (Del.
Dec. 23, 2003). There are no such flaws here.
40
REDACTED
41
REDACTED
REDACTED
entity and advisor to a fund in which Goldman invested 464 million and $600
million, respectively). In re Loral Space & Commcns., Inc., 2008 WL 4293781,
at *5, *20 (Del. Ch. Sept. 19, 2008), on which Plaintiff relies (Pl. Mem. 47), is
inapposite the director was a long-time friend[] of the CEO who was
responsible for the CEOs appointment and had been the CEOs rent-free tenant
and advisor.
REDACTED
REDACTED
Am., Inc., 1991 WL 67083, at *5 (Del. Ch. Apr. 26, 1991). No such showing has
been, or can be, made here.
Fifth,
REDACTED
But Truong is also on TERPs board, see Ex. 40, and SunEdison is
obligated to arrange for advisors, expressly including legal advisors or at the
Committees request. Ex. 7 3.1, 3.2.
Precisely the same
REDACTED
REDACTED
for the perfectly appropriate reasons that they were highly qualified and
independent.
In Western National,
REDACTED
REDACTED
REDACTED
REDACTED
advised the Committee it was not bound to the Take/Pay because it was only an
unsigned term sheet
REDACTED
is legally infirm.
46
REDACTED
Sixth,
REDACTED
REDACTED
47
REDACTED
inference of unfair dealing. To be sure, our case law recognizes that establishing
an independent negotiating committee, and obtaining an investment banker
fairness opinion (or asset appraisal), are indicia of fair dealing in a merger. But
those authorities do not impose an affirmative fiduciary duty to implement one or
more of these procedural safeguards, with the result that a failure to do so would
constitute actionable unfair dealing. Seagraves v. Urstadt Prop. Co., 1989 WL
137918, at *4 (Del. Ch. Nov. 13, 1989) (fairness opinion is an indication of fair
dealing in a merger, but failure to do so does not constitute actionable unfair
dealing).
An entire fairness inquiry must focus on how the special committee
actually negotiated the deal and the substance, and efficacy, of the special
committees negotiations. In re S. Peru Copper Corp. Sholder Deriv. Litig., 52
A.3d 761, 789 (Del. Ch. 2011).
REDACTED
48
2.
Even if there had been flaws in the Conflicts Committee process rising to the
level of unfair dealing and there were none the economic terms the
Committee negotiated were fair and should thus be upheld. See, e.g., Trados, 73
A.3d at 76, 78 (fiduciaries did not breach their duties when they failed to follow a
fair process yet nevertheless approved a transaction that yielded a fair price); Del.
Open MRI Radiology Assocs., P.A. v. Kessler, 898 A.2d 290, 310 (Del. Ch. 2006)
([T]he bottom line outcome of the caseturns on whether the merger was
financially fair.); In re Hanover Direct, Inc. Sholders Litig., 2010 WL 3959399,
at *2 (Del. Ch. Sept. 24, 2010) (The issue of fair process is secondary to the
ultimate import of fair price....).
REDACTED
allegation that the economic terms of the December Amendments are unfair
49
REDACTED
Partners, L.P., 855 A.2d 1059, 1080 (Del. Ch. 2003), affd, 840 A.2d 641 (Del.
2003); see also In re Appraisal of Dole Food Co., 114 A.3d 541, 558 (Del. Ch.
2014).
Take/Pay.
TERPs decision to enter into a Take/Pay Agreement in July, to achieve the welldocumented benefits to TERP of the entire transaction.
Hallmark Entmt Invs. Co., 2011 WL 863007, at *16 (Del. Ch. Mar. 9, 2011) (the
court asks whether the transaction was one that a reasonable seller, under all of the
circumstances, would regard as within a range of fair value; one that such a seller
could reasonably accept); Lonergan v. EPE Holdings, LLC, 5 A.3d 1008, 1020
(Del. Ch. 2010) (a Delaware court determines entire fairness based on all aspects
of the entire transaction). That decision is one that Plaintiff has neither standing
nor evidence to challenge.
REDACTED
51
REDACTED
11
REDACTED
See also Weldin Farms, Inc. v. Glassman, 414 A.2d 500, 505 (Del. 1980)
([A]n injunction will not issue by reason of mere apprehension of uncertain
speculative damage at an indefinite time in the future.); Angelo, Gordon & Co. v.
Allied Riser Commcns Corp., 805 A.2d 221, 231 (Del. Ch. 2002) (no irreparable
harm where injuries are both speculative and [would] not result from the Merger
itself but [would] only be felt, if at all, with the passage of time after the Merger).
52
REDACTED
REDACTED
53
REDACTED
REDACTED
[A]n event that might or might not occur does not show irreparable harm.
H.F. Ahmanson & Co. v. Great W. Fin. Corp., 1997 WL 305824, at *11 (Del. Ch.
June 3, 1997). Plaintiffs claim of a possible 2017 insolvency of TERP is purely
conjectural.
B.
Plaintiff asserts that TERP would be unable to collect money damages were
it to prevail against SunEdison in trial. Pl. Mem. 56-59; 133-35. There is no
basis for this assertion. Plaintiff does not quantify the amount that SunEdison
would theoretically be unable to pay. As shown above, that amount cannot exceed
REDACTED
54
REDACTED
12
The other case Plaintiff cites, Bayard v. Martin, 101 A.2d 329, 335 (Del.
1953), also establishes that Plaintiffs failure to make an affirmative showing of
SunEdisons future insolvency is insufficient.
55
C.
harm than good. Lennane v. ASK Comp. Sys., Inc., 1990 WL 154150, at *6 (Del.
Ch. Oct. 11, 1990), appeal refused, 1990 WL 169078 (Del. Oct. 19, 1990) (Del.
Oct. 19, 1990).
An injunction would preclude the Vivint merger by disabling SunEdisons
ability to finance it with cash from the Goldman Loan or proceeds of the Amended
Purchase Agreements.
shareholders.
56
Plaintiff argues that the duty to close the Vivint merger would be suspended
by entry of an injunction, citing 6.01(b) of the Amended Merger Agreement. Pl.
Mem. 60. But the only immediate effect of the injunction would be to prevent
SunEdison from accessing its financing, which is dependent on the existence of the
Take/Pay. SunEdisons duty to close under the Amended Merger Agreement is not
conditioned on financing. Ex. 69 at 4.05(a) (obligations to perform...including
to consummate the Closing...are not conditioned on...the Debt Financing or any
other financing).
SunEdison immediately because March 18, 2016 is the merger termination date.
Id. at 7.01(c).
If Vivint were to sue and prevail on its reading of the contract that an
injunction preventing the financing does not excuse closing because financing is
expressly carved out of the conditions to closing SunEdison would be forced
into the impossible position of having to close anyway (which it will be unable to
do) or paying damages, which contractually include the losses suffered by Vivint
shareholders for not receiving the merger consideration.
Id. at 7.02.
(Shareholders separately have the right to sue for the merger consideration, id. at
8.06(iii).)
REDACTED
57
REDACTED
to post a bond commensurate with the extreme harm that may result. See AM Gen.
Holdings LLC v. Renco Grp., 2012 WL 6681994, at *7 (Del. Ch. Dec. 21, 2012);
Sanofi-Synthelabo v. Apotex Inc., 488 F. Supp. 2d 317, 349 (S.D.N.Y. 2006)
(requiring $400 million bond based on potential lost profits, lost market share and
associated costs of relaunch stemming from preliminary injunction barring
distribution of prescription drug), affd, 470 F.3d 1368 (Fed. Cir. 2006).
Specifically, because a wrongful injunction of the Challenged Transaction would
disable SunEdison from closing the Vivint merger due to lack of financing, would
expose SunEdison to
and
REDACTED
REDACTED
59
REDACTED
OF COUNSEL:
Gregory P. Joseph
Pamela Jarvis
Mara Leventhal
Honey Kober
Gregory O. Tuttle
Roman Asudulayev
Joseph Hage Aaronson LLC
485 Lexington Avenue
30th Floor
New York, New York 10017
(212) 407-1210
60